A Detailed Growth Analysis of the Multiomics Market Based on the Rising Need for Personalized Medicine, and the Increasing Prevalence of Cancer and Other Chronic Diseases
Report ID: PMRREP33840
Number of Pages: 190
Format: PPT*, PDF, EXCEL
Industry: Healthcare
Published Date: January-2024
1. Executive Summary
1.1. Global Multiomics Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Product and Service Lifecycle Analysis
2.4. Multiomics Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Multiomics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Multiomics Market Outlook: Product and Service
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product and Service, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product and Service, 2023 - 2030
3.3.3.1. Products
3.3.3.2. Instruments
3.3.3.3. Consumables
3.3.3.4. Software
3.3.3.5. Services
3.4. Market Attractiveness Analysis: Product and Service
3.5. Global Multiomics Market Outlook: Type
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Type, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
3.5.3.1. Single-cell Multiomics
3.5.3.2. Bulk Multiomics
3.6. Market Attractiveness Analysis: Type
3.7. Global Multiomics Market Outlook: Application
3.7.1. Introduction / Key Findings
3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Application, 2018 - 2022
3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
3.7.3.1. Cell Biology
3.7.3.2. Oncology
3.7.3.3. Neurology
3.7.3.4. Immunology
3.8. Market Attractiveness Analysis: Application
3.9. Global Multiomics Market Outlook: End User
3.9.1. Introduction / Key Findings
3.9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
3.9.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
3.9.3.1. Academic and Research Institutes
3.9.3.2. Pharmaceutical & biotechnology companies
3.9.3.3. Others
3.10. Market Attractiveness Analysis: End User
4. Global Multiomics Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia and Oceania
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Multiomics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Product and Service
5.3.3. By Type
5.3.4. By Application
5.3.5. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product and Service, 2023 - 2030
5.5.1. Products
5.5.2. Instruments
5.5.3. Consumables
5.5.4. Software
5.5.5. Services
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
5.6.1. Single-cell Multiomics
5.6.2. Bulk Multiomics
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
5.7.1. Cell Biology
5.7.2. Oncology
5.7.3. Neurology
5.7.4. Immunology
5.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
5.8.1. Academic and Research Institutes
5.8.2. Pharmaceutical & biotechnology companies
5.8.3. Others
5.9. Market Attractiveness Analysis
6. Europe Multiomics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Product and Service
6.3.3. By Type
6.3.4. By Application
6.3.5. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Turkey
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product and Service, 2023 - 2030
6.5.1. Products
6.5.2. Instruments
6.5.3. Consumables
6.5.4. Software
6.5.5. Services
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
6.6.1. Single-cell Multiomics
6.6.2. Bulk Multiomics
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
6.7.1. Cell Biology
6.7.2. Oncology
6.7.3. Neurology
6.7.4. Immunology
6.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
6.8.1. Academic and Research Institutes
6.8.2. Pharmaceutical & biotechnology companies
6.8.3. Others
6.9. Market Attractiveness Analysis
7. East Asia Multiomics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Product and Service
7.3.3. By Type
7.3.4. By Application
7.3.5. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product and Service, 2023 - 2030
7.5.1. Products
7.5.2. Instruments
7.5.3. Consumables
7.5.4. Software
7.5.5. Services
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
7.6.1. Single-cell Multiomics
7.6.2. Bulk Multiomics
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
7.7.1. Cell Biology
7.7.2. Oncology
7.7.3. Neurology
7.7.4. Immunology
7.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
7.8.1. Academic and Research Institutes
7.8.2. Pharmaceutical & biotechnology companies
7.8.3. Others
7.9. Market Attractiveness Analysis
8. South Asia & Oceania Multiomics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Product and Service
8.3.3. By Type
8.3.4. By Application
8.3.5. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product and Service, 2023 - 2030
8.5.1. Products
8.5.2. Instruments
8.5.3. Consumables
8.5.4. Software
8.5.5. Services
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
8.6.1. Single-cell Multiomics
8.6.2. Bulk Multiomics
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
8.7.1. Cell Biology
8.7.2. Oncology
8.7.3. Neurology
8.7.4. Immunology
8.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
8.8.1. Academic and Research Institutes
8.8.2. Pharmaceutical & biotechnology companies
8.8.3. Others
8.9. Market Attractiveness Analysis
9. Latin America Multiomics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Product and Service
9.3.3. By Type
9.3.4. By Application
9.3.5. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product and Service, 2023 - 2030
9.5.1. Products
9.5.2. Instruments
9.5.3. Consumables
9.5.4. Software
9.5.5. Services
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
9.6.1. Single-cell Multiomics
9.6.2. Bulk Multiomics
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
9.7.1. Cell Biology
9.7.2. Oncology
9.7.3. Neurology
9.7.4. Immunology
9.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
9.8.1. Academic and Research Institutes
9.8.2. Pharmaceutical & biotechnology companies
9.8.3. Others
9.9. Market Attractiveness Analysis
10. Middle East & Africa Multiomics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Product and Service
10.3.3. By Type
10.3.4. By Application
10.3.5. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product and Service, 2023 - 2030
10.5.1. Products
10.5.2. Instruments
10.5.3. Consumables
10.5.4. Software
10.5.5. Services
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
10.6.1. Single-cell Multiomics
10.6.2. Bulk Multiomics
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
10.7.1. Cell Biology
10.7.2. Oncology
10.7.3. Neurology
10.7.4. Immunology
10.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
10.8.1. Academic and Research Institutes
10.8.2. Pharmaceutical & biotechnology companies
10.8.3. Others
10.9. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Instruments
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. BD
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. Thermo Fisher Scientific Inc.
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. Illumina, Inc
11.3.3.1. Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Danaher
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. PerkinElmer Inc.
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. Shimadzu Corporation
11.3.6.1. Overview
11.3.6.2. Segments and Product
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Bruker
11.3.7.1. Overview
11.3.7.2. Segments and Product
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. QIAGEN
11.3.8.1. Overview
11.3.8.2. Segments and Product
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. Agilent Technologies, Inc.
11.3.9.1. Overview
11.3.9.2. Segments and Product
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
11.3.10. BGI
11.3.10.1. Overview
11.3.10.2. Segments and Product
11.3.10.3. Key Financials
11.3.10.4. Market Developments
11.3.10.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations